These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32622992)

  • 1. N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: An updated meta-analysis based on 54 case-control studies.
    Song Y; Qi X; Liu X
    Gene; 2020 Oct; 757():144924. PubMed ID: 32622992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group.
    Xu WJ; Wen LP; Jiang XX; Ye LY; Meng FH; Guan S; Qian YJ; Wei JF
    Clin Lab; 2017 Feb; 63(2):287-293. PubMed ID: 28182356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAT2 gene polymorphisms and endometriosis risk: A PRISMA-compliant meta-analysis.
    Wei Z; Zhang M; Zhang X; Yi M; Xia X; Fang X
    PLoS One; 2019; 14(12):e0227043. PubMed ID: 31881062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups.
    Ma QW; Lin GF; Chen JG; Xiang CQ; Guo WC; Golka K; Shen JH
    Biomed Environ Sci; 2004 Sep; 17(3):291-8. PubMed ID: 15602826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.
    Quan L; Chattopadhyay K; Nelson HH; Chan KK; Xiang YB; Zhang W; Wang R; Gao YT; Yuan JM
    Oncotarget; 2016 Jun; 7(26):40012-40024. PubMed ID: 27223070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
    Song Y; Yang Y; Liu L; Liu X
    Gene; 2019 May; 698():186-197. PubMed ID: 30849545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione S-Transferase Pi 1 (GSTP1) Gene 313 A/G (rs1695) polymorphism is associated with the risk of urinary bladder cancer: Evidence from a systematic review and meta-analysis based on 34 case-control studies.
    Song Y; Chen J; Liu K; Zhou K; Lu Y; Wang X; Yang Y; Liu X
    Gene; 2019 Nov; 719():144077. PubMed ID: 31454540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
    Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
    Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
    Wu H; Wang X; Zhang L; Mo N; Lv Z
    Clin Genitourin Cancer; 2016 Apr; 14(2):122-9. PubMed ID: 26585839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population.
    Cui X; Lu X; Hiura M; Omori H; Miyazaki W; Katoh T
    Environ Health Prev Med; 2013 Mar; 18(2):136-42. PubMed ID: 22961351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
    Gu J; Liang D; Wang Y; Lu C; Wu X
    Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
    Avirmed S; Khuanbai Y; Sanjaajamts A; Selenge B; Dagvadorj BU; Ohashi M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2479-2485. PubMed ID: 34452561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.
    Moore LE; Baris DR; Figueroa JD; Garcia-Closas M; Karagas MR; Schwenn MR; Johnson AT; Lubin JH; Hein DW; Dagnall CL; Colt JS; Kida M; Jones MA; Schned AR; Cherala SS; Chanock SJ; Cantor KP; Silverman DT; Rothman N
    Carcinogenesis; 2011 Feb; 32(2):182-9. PubMed ID: 21037224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population.
    Klimčáková L; Habalová V; Sivoňová M; Nagy V; Šalagovič J; Židzik J
    Mol Biol Rep; 2011 Feb; 38(2):1287-93. PubMed ID: 20568013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer.
    Risch A; Wallace DM; Bathers S; Sim E
    Hum Mol Genet; 1995 Feb; 4(2):231-6. PubMed ID: 7757072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.